Navigation Links
Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
Date:5/12/2008

by total sales. Approximately 30 percent (eight medicines) of Lilly's total drug portfolio are biotech medicines in several therapeutic categories, representing about $4.4 billion of the company's 2007 sales. Biotech medicines also represented one-third of the company's drug pipeline at the end of 2007.

AME

The construction of the three buildings in Indianapolis that make up the Biotechnology Complex, along with Lilly's acquisition in 2004 of Applied Molecular Evolution - a San Diego-based operation that conducts protein optimization research accounts for a total biotech capital investment of approximately $1 billion.

Kinsale

On April 9, 2008, Lilly Chief Executive Officer John Lechleiter traveled to Ireland for the groundbreaking of the Kinsale biopharmaceutical manufacturing facility. The Kinsale facility will scale up the manufacturing of the biopharmaceuticals discovered in Indianapolis to treat illnesses such as cancer, diabetes and Alzheimer's disease. The 400 million Euro investment will bring an additional 200 jobs to the area. Lilly currently employs more than 400 people at the Kinsale site, which the company opened in 1981.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com .

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

C-LLY


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth
2. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
3. Lilly Reports Solid First-Quarter Results
4. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
5. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
6. Lilly Announces Termination of AIR Insulin Program
7. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
8. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
9. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
10. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
11. Lilly Declares Fourth-Quarter Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... California (PRWEB) January 22, 2015 Eckert ... Accelerator Mass Spectrometry (AMS) services to the pharmaceutical and ... has joined the company in the position of Director ... years of broad and valuable experience in drug metabolism ...
(Date:1/22/2015)... 2015 Cambridge Semantics, the leading provider of ... that 2014 was a record-breaking year across the board for ... Anzo Smart Data Platform and our Smart Data solutions, our ... diverse data which led to record growth for the company ...
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
(Date:1/22/2015)... NEW BRUNSWICK , Nueva Jersey , 22 ... Award for Biomedical Research abre hoy su llamada ... las personas cuya investigación científica ha hecho, o tiene ... de la salud humana. Las nominaciones se aceptarán hasta ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Cambridge Semantics Announces Record Results for 2014 23D Motion Capture Just Got Easy 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... May 11 deCODE genetics,(Nasdaq: DCGN ) today ... 31, 2009. A conference call to discuss these results ... live tomorrow,Tuesday, May 12, at 8:00am Eastern Daylight Time/12 ... Net loss for the quarter ended March ...
... May 11 Sinobiopharma, Inc. (OTC Bulletin Board: ... announce that it has received approval from the ... manufacture and market its formulation of Perindopril, an ... other medications to treat high blood pressure, is ...
... helps healthcare providers build competence and confidence while keeping ... Corporation ( MSC ) will launch the ... Teaching Institute (NTI) and Critical Care Exposition, the world,s ... critically ill patients, May 16-21, in New Orleans, LA. ...
Cached Biology Technology:deCODE genetics Announces First Quarter 2009 Financial Results 2deCODE genetics Announces First Quarter 2009 Financial Results 3deCODE genetics Announces First Quarter 2009 Financial Results 4deCODE genetics Announces First Quarter 2009 Financial Results 5deCODE genetics Announces First Quarter 2009 Financial Results 6deCODE genetics Announces First Quarter 2009 Financial Results 7deCODE genetics Announces First Quarter 2009 Financial Results 8Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug Perindopril 2Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition 2Medical Simulation Corporation to Introduce Central Line Management Program at the National Teaching Institute and Critical Care Exposition 3
(Date:12/19/2014)...  23andMe, Inc., the leading personal genetics company, today announced the ... ancestry of individuals from across the United States ... four hundred years ago, the United States ... different continents. This study illuminates how American history and the ...
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ...
(Date:12/11/2014)... 2014 Research and Markets , ... has announced the addition of the "Biometrics Market ... One major trend emerging in this market ... systems utilize more than one characteristic of an individual ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... to a REM sleep deprivation procedure reduces cell proliferation ... long-term memory of rats, according to a study published ... The study, authored by Dennis McGinty, PhD, of ... male Sprague-Dawley rats. REM sleep deprivation was achieved ...
... experimental biomarker test developed by researchers at the University ... other screening method currently in use, according to a ... Research, a journal of the American Association for Cancer ... that screens for the presence of four different ...
... the worlds poorest regions could face severe crop losses in ... a new study by researchers at Stanford Universitys Program on ... be published in the Feb. 1 issue of the journal ... depend on agriculture for their livelihoods, said lead author David ...
Cached Biology News:4 days of REM sleep deprivation contributes to a reduction of cell proliferation in rats 2New, noninvasive prostate cancer test beats PSA in detecting prostate cancer 2New, noninvasive prostate cancer test beats PSA in detecting prostate cancer 3Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 2Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 3Impoverished areas of Africa and Asia face severe crop losses from climate change in 20 years 4
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ID ...
This modular laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Configurations are available with vertical or horizontal flow; options include a wo...
...
Denhardt's powder mixture (for 50X stock solution)...
Biology Products: